| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,684 |
2,263 |
$525K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
903 |
822 |
$194K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,247 |
1,107 |
$72K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
364 |
331 |
$29K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
121 |
102 |
$19K |
| 80053 |
Comprehensive metabolic panel |
2,384 |
2,011 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
232 |
196 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,442 |
2,049 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
259 |
240 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
393 |
351 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
111 |
83 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
17 |
15 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
149 |
134 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
114 |
99 |
$2K |
| 80061 |
Lipid panel |
111 |
93 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
35 |
34 |
$547.31 |
| E1390 |
Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate |
75 |
49 |
$534.41 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
49 |
28 |
$378.30 |
| 81003 |
|
912 |
801 |
$342.26 |
| 90686 |
|
50 |
50 |
$337.55 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
78 |
78 |
$328.51 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
55 |
53 |
$238.04 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
57 |
44 |
$217.15 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
76 |
67 |
$178.22 |
| 83735 |
|
201 |
179 |
$93.36 |
| A9270 |
Non-covered item or service |
1,829 |
1,197 |
$77.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
53 |
48 |
$37.20 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
170 |
159 |
$21.82 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
114 |
106 |
$6.34 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
12 |
$5.26 |
| 83605 |
|
14 |
12 |
$0.00 |
| J3490 |
Unclassified drugs |
47 |
27 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
12 |
12 |
$0.00 |